Solara Active Pharma Sciences (NSE:SOLARAPP1) EPS (Basic): ₹-1.68 (TTM As of Mar. 2026)


NSE:SOLARAPP1 Solara Active Pharma Sciences Ltd NSE:SOLARAPP1
68 GF Score
Price ₹267.45
GF Value ₹258.52
! 3 Warning Signs
View Full Analysis

What is Solara Active Pharma Sciences EPS (Basic)?

Solara Active Pharma Sciences NSE:SOLARAPP1 68 EPS (Basic) is ₹-1.68 as of Mar. 2026. GuruFocus rates NSE:SOLARAPP1 with a GF Score™ of 68/100 and a GF Value™ of ₹258.52. The stock has 3 warning signs investors should review.

Solara Active Pharma Sciences's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹2.20. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-1.68.

Solara Active Pharma Sciences's EPS (Diluted) for the three months ended in Mar. 2026 was ₹2.20. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-1.68.

Solara Active Pharma Sciences's EPS without NRI for the three months ended in Mar. 2026 was ₹2.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.34.

During the past 12 months, Solara Active Pharma Sciences's average EPS without NRIGrowth Rate was -346.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was 60.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Solara Active Pharma Sciences's highest 3-Year average EPS without NRI Growth Rate was 60.80% per year. The lowest was 11.40% per year. And the median was 36.10% per year.

Solara Active Pharma Sciences  (NSE:SOLARAPP1) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Solara Active Pharma Sciences EPS (Basic) Related Terms

Solara Active Pharma Sciences EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Solara Active Pharma Sciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solara Active Pharma Sciences EPS (Basic) Chart

Solara Active Pharma Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.91 -5.68 -148.51 0.14 -1.68

Solara Active Pharma Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.93 2.46 -2.36 -3.98 2.20
NSE:SOLARAPP1
68GF Score
Solara Active Pharma Sciences Ltd NSE:SOLARAPP1
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solara Active Pharma Sciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Solara Active Pharma Sciences's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-74.1-0)/44.107
=-1.68

Solara Active Pharma Sciences's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(96-0)/43.636
=2.20

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-1.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹-1.68 mean?
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a EPS (Basic) of ₹-1.68 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Solara Active Pharma Sciences and its competitors.
Is Solara Active Pharma Sciences' EPS (Basic) too high?
Solara Active Pharma Sciences' current EPS (Basic) is ₹-1.68. Overall, Solara Active Pharma Sciences has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Solara Active Pharma Sciences' EPS (Basic) compare to ZTS?
Solara Active Pharma Sciences' EPS (Basic) of ₹-1.68 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Solara Active Pharma Sciences and its competitors. Solara Active Pharma Sciences's current EPS (Basic) is ₹-1.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solara Active Pharma Sciences stock overvalued right now?
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a current EPS (Basic) of ₹-1.68. The stock's GF Value™ is ₹258.52, compared to a current price of ₹267.45 — trading 3.5% above its estimated fair value. The current EPS (Basic) is ₹-1.68. Solara Active Pharma Sciences' overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Solara Active Pharma Sciences (NSE:SOLARAPP1), the current EPS (Basic) is ₹-1.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Solara Active Pharma Sciences (NSE:SOLARAPP1) Overvalued in 2026?

Based on GuruFocus' analysis, Solara Active Pharma Sciences stock appears to be overvalued. The current stock price of ₹267.45 is trading 3.5% above its estimated GF Value™ of ₹258.52.

Key valuation signals for NSE:SOLARAPP1:

  • EPS (Basic): ₹-1.68
  • GF Value™: ₹258.52 vs. price of ₹267.45 (3.5% above fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the NSE:SOLARAPP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Solara Active Pharma Sciences Business Description

Other Exchanges SOLARA:India541540:India
Address Phase II - CSIR Road, Module No. 601, 602, 603, Ticel Bio Park, Taramani, Chennai, TN, IND, 600113
Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.
68GF Score

Get the complete analysis for NSE:SOLARAPP1

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹267.45
Price
₹258.52
GF Value